Does Dr. ALEXEY ACOSTA QUINTANA have financial conflicts of interest?

Dr. ALEXEY ACOSTA QUINTANA (MD) has received a total of $180 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $180 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ALEXEY ACOSTA QUINTANA?

According to CMS Open Payments data, Dr. ALEXEY ACOSTA QUINTANA received funding from BAYER HEALTHCARE PHARMACEUTICALS ($53), CRANIAL TECHNOLOGIES ($48), and ASTELLAS PHARMA US ($42).

Does Dr. ALEXEY ACOSTA QUINTANA receive research grants or speaking fees?

Dr. ALEXEY ACOSTA QUINTANA has received $180 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ALEXEY ACOSTA QUINTANA

MDReal-Time Hydrated

Specialty: Nurse Practitioner, Family

Practice Location: FAIRDALE, KY 40118

NPI Number: 1639818867

LIFETIME INDUSTRY VALUE

$180

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ACOSTA QUINTANA is a verified Nurse Practitioner, Family practitioner based in FAIRDALE, KY.

Between 2021 and 2025, Dr. ACOSTA QUINTANA had an overall industry promotional and research financial footprint of $180 as recorded in the federal CMS Open Payments database.

$180 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ACOSTA QUINTANA's primary funding source is BAYER HEALTHCARE PHARMACEUTICALS, which accounts for $53 (representing 29.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BAYER HEALTHCARE PHARMACEUTICALS

Rank 1

$53

29.3%

CRANIAL TECHNOLOGIES

Rank 2

$48

26.5%

ASTELLAS PHARMA US

Rank 3

$42

23.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.